AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Jonathan D. Rockoff
Jun. 9--WASHINGTON--Federal regulators are attempting to crack down on the sale of unapproved and potentially deadly prescription drugs, warning manufacturers yesterday to stop selling cough drops and syrups containing a common antihistamine if they haven't received government permission.
Food and Drug Administration officials expressed special alarm that the ingredient carbinoxamine, approved only to fight allergy symptoms, is being sold to treat children under the age of 2, even though its use for coughs and colds has never been tested.
The agency has 21 reports of deaths among children under 2 who took medicines…
Source: HighBeam Research, FDA warns of cold drugs.